Intas Pharmaceuticals

Press Release

Kashiv BioSciences and Intas Pharmaceuticals Sign an Exclusive Licensing and Supply Agreement for Complex Peptide Product in Europe, the UK & India

PISCATAWAY, N.J., [February 10, 2026]: Kashiv BioSciences, LLC (“Kashiv”) a vertically integrated biopharmaceutical company, today announced that it has entered into an exclusive licensing and supply agreement with Intas Pharmaceuticals Ltd (“Intas”), a leading multinational pharmaceutical company. The complex peptide product will be commercialized by Intas in India and its subsidiary, Accord Healthcare Ltd (“Accord”), in Europe and the UK.…